The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Cancer modeling meets human organoid technology
Open accessAbstract
Organoids are microscopic self-organizing, three-dimensional structures that are grown from stem cells in vitro. They recapitulate many structural and functional aspects of their in vivo counterpart organs. This versatile technology has led to the development of many novel human cancer models. It is now possible to create indefinitely expanding organoids starting from tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer through the introduction of any combination of cancer gene alterations to normal organoids. When combined with immune cells and fibroblasts, tumor organoids become models for the cancer microenvironment enabling immune-oncology applications. Emerging evidence indicates that organoids can be used to accurately predict drug responses in a personalized treatment setting. Here, we review the current state and future prospects of the rapidly evolving tumor organoid field.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“dynamic drug treatment was more effective than constant‐dose administration methods.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“Using this system, the authors observed that significant differences in the response of individual PDOs to specific drug treatments and dynamic drug treatments could be more effective than constant‐dose therapy in vitro, indicating that this platform holds great potential to make clinical decisions for personalized therapy.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“Using this system, the authors observed that significant differences in the response of individual PDOs to specific drug treatments and dynamic drug treatments could be more effective than constant‐dose therapy in vitro, indicating that this platform holds great potential to make clinical decisions for personalized therapy.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“APCmin/+ mice can develop intestinal tumors around 10 weeks-old26”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“Wnt/β-catenin signaling is essential to maintain intestinal organoid growth26,27”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“The patient-derived tumor organoids, which recapitulate the complexity and heterogeneity of tumors, have been shown to be an ideal model for drug screening and precision medicine26.”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“These tumoroid biobanks can then be used as in vitro models of tumorigenesis and offer a significant advantage over conventional 2D cell culture technology5,6.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [6]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Self-citationCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Self-citationDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Self-citationProspective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Self-citationOrganoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Self-citationPatient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Self-citationBasal cells as stem cells of the mouse trachea and human airway epithelium
Rock, J. R., Onaitis, M. W., Rawlins, E. L., Lu, Y., Clark, C. P., Xue, Y., Randell, S. H., & Hogan, B. L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906850106 · Cited by 1,591
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–938 of 938
A 3D Bioprinted Platform That Maintains the Functional Integrity of Primary AML Cells
Huang, W. Y., Deng, B., Guo, N., Ding, Y., Xu, Z., Lu, Y., Ma, Y., Ren, Q., Wang, N., Huang, P., et al. (2026) · Cell Proliferation · doi:10.1111/cpr.70250
Yang, S., guo, J., Wang, W., Feng, Z., Wang, L., & Xu, M. (2026) · Biomedical Optics Express · doi:10.1364/boe.604536
Badmos, H. A., Steele, C. W., & Cagan, R. L. (2026) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5752
Phanthaphol, N., Kanoksing, P., Riansuwan, W., Prapasrivorakul, S., Ovartchaiyapong, P., Mongkhonsupphawan, A., Phumphuang, S., Junking, M., Thuwajit, P., Yenchitsomanus, P., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-05004-6 · Cited by 1
Patient-derived organoids as a predictive platform for drug sensitivity in bladder cancer
Hekmatirad, S., Gholizadeh, F., Montazeri, S., Sharifi, L., Nowroozi, M. R., Hamidieh, A. A., Yazdi, M. H., & Sisakht, M. M. (2026) · Scientific Reports · doi:10.1038/s41598-026-59564-x
Sharma, R., & Kaushal, R. (2026) · RSC Advances · doi:10.1039/d6ra00615a
Sun, C., Wu, G., Wu, D., Du, Q., Lu, Q. W., Hu, W., Wang, J., xie, A., Yao, Z., Xia, M., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.06.041
Demianova, S., Dierolf, M., Reichert, M., Schmidleitner, L., Pfeiffer, F., & Weber, W. (2026) · EJNMMI Research · doi:10.1186/s13550-026-01484-y
Culture and Expansion of Circulating Tumor Cells from Breast Malignant Effusions as Organoids
Parizadeh, A., Warhadpande, S., Magbanua, M. J., & Rosenbluth, J. M. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5050-9_22
Lupo, B., Catalano, I., & Trusolino, L. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02747-x
Kaur, P., Bhattacharyya, S., Gupta, P., Khare, S., Irrinki, S., & Bal, A. (2026) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001344
Sarkar, O., & Othayoth, R. (2026) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000151
Xu, Z., Li, S., Tu, S., Yu, M., Peng, H., Chen, F., Qian, K., Wang, G., Yu, X., & Ju, L. (2026) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000158
Construction and Application of the Organoid Model for Triple-Negative Breast Cancer
柳, 思. (2026) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2026.54228
dECM bioinks for 3D bioprinted tumor models: Advances, challenges, and drug screening
Chen, Q., Zhou, R., Xu, Q., Li, Z., & Tao, J. (2026) · iScience · doi:10.1016/j.isci.2026.117085 · Cited by 1
Syphers, J. L., Wright, J. A., Kumar, A., To, N., Elson, L., Krämer, A., Müller, S., Morasch, V., Chang, A., Young, S., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00018
Miyamoto, R., Yoshida, K., Matsuoka, Y., Sasagawa, S., Nagamine, N., Kukita, Y., Sabe, H., Yoshimura, Y., Takami, H., Suzuki, R., et al. (2026) · Human Cell · doi:10.1007/s13577-026-01441-w
Chen, L., Fu, X., Dong, W., Deng, X., Chen, S., Wang, F., Zhao, J., Shao, S., Fan, L., Zhang, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.19.745708
Liang, J., Gondane, A., & Itkonen, H. M. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71323
Baratti, D., Varinelli, L., Guagliò, M., D, S. K. M., Cavalleri, T., Battistessa, D., Sabella, G., Colletti, G., Gariboldi, M., & D, M. D. M. (2026) · Cancers · doi:10.3390/cancers18162722
Li, Y., Yang, Y., Zhao, L., Bian, Z., & Zhang, Z. (2026) · Bioengineering · doi:10.3390/bioengineering13080947
Data-centric feedback loops for next-generation immunotherapy development
Shalita, R., & Amit, I. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01785-6
García, A., Jove, L., Pereira, M., Figueroa, A., & Nieto, D. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103646
Tanna, H., & Shah, S. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2726313
The Osteosarcoma Tumor Microenvironment: From Cellular Interactions to Advanced Preclinical Models
Feo, G. D., Paola, A. D., Domenico, O. D., Argenziano, L., Pota, E., Pinto, D. D., Martino, M. D., Marrapodi, M. M., & Rossi, F. (2026) · Cancers · doi:10.3390/cancers18182909
Fırat, Y., & Kılıçaslan, Y. (2026) · Biology · doi:10.3390/biology15191782
Fomina, A., Tam, A., Lam, J., Wu, N. C., Li, N. T., & McGuigan, A. P. (2026) · Advanced Materials Technologies · doi:10.1002/admt.71311
A Tissue Explant Model for Colon Cancer
Epiney, J., Gussago, S., Saint-Amour, P., Khallouf, J., Torres, T., Vuagniaux, A., Colucci, N., Butti, F., Bretagnol, F., Koessler, T., et al. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5412-5_22
Lei, X., Song, B., Jin, D., Zhou, J., Guo, T., & Kong, J. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1848297
Tumor organoids for testing metabolic flexibility in precision oncology
Hao, D., Ren, Y., & Zhang, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1902688
Sun, H., Liu, K., Wang, J., Qi, H., Gan, P., Hu, W., Sun, H., Wang, Y., & Liang, Q. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101801
Tian, H., Li, G., Lian, Y., Liu, H., Fang, Y., Tong, Y., He, Z., Bian, Y., & Wei, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1926341
The Missing Variability Problem in Cancer Prediction: Integrating Multilevel Factors
Шевченко, С. Ю. (2026) · Biological Theory · doi:10.1007/s13752-026-00554-7
Jabri, A., Alsharif, M., Mhannayeh, A., Taftafa, B., Sibai, D., Elsalti, A., Alsharif, R., Mir, T. A., Khan, M. I., Salma, J., et al. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70321
Zielinska, D., Fol, M., & Druszczyńska, M. (2026) · Vaccines · doi:10.3390/vaccines14100908
Body-on-chip systems and clinical biomarkers discovery
Härtung, T., & Smirnova, L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00008-x
Rae, C. J., O’Rourke, C. J., Tesini, G., Greaves, J., Rink, C., Nixon, C., Vlachogiannis, G., Munro, A. F., Pijnenburg, D., Cardinale, V., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.102083
Metadata
- Authors
- Tuveson, D., & Clevers, H.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- Corresponding author
- Tuveson, David
- Clevers, Hans
- Venue
- Science
- Published
- 2019-06-07
- Volume
- 364
- Issue
- 6444
- Pages
- 952-955
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2948402706
- Cited by
- 935
- References
- 53
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 134 · 2023: 156 · 2022: 125 · 2021: 154 · 2020: 116 · 2019: 15
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- National Cancer Institute (NIH 5P30CA45508-29, 5P50CA101955-07, P20CA192996-03, U01CA210240-01A1, 1R01CA188134-01)
- Lustgarten Foundation (Dedicated Laboratory)
- European Research Council (EU-ERC-670133 Organoid)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- tumor organoids, tumor models, organoid engineering, CRISPR gene editing, tumor microenvironment, cancer immunotherapy, drug response prediction, precision oncology, stem cell-derived organoids, fibroblasts, immune cells
- MeSH terms
- Gene Editing, Humans, Models, Biological, Neoplasms, Organoids, Stem Cells, Biological Specimen Banks, Coculture Techniques, Precision Medicine, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
